Results 261 to 270 of about 385,846 (332)

From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple Sclerosis

Annals of Neurology, EarlyView.
Objective The growing demand for personalized treatment in multiple sclerosis (MS) highlights the need for more precise biomarkers that can outperform magnetic resonance imaging and clinical assessment in patient stratification. Advances in multiplex proteomic technologies suggest that cerebrospinal fluid (CSF) analysis at MS onset may not only improve
Laura Ghezzi, Peter Kosa, Mark Greenwood, Enrique Alvarez, C.L. Freedman, Anne H. Cross, Francesca Pace, Mark S. Freedman, Joanna Kocot, Laura Piccio, Bibiana Bielekova   +10 more
wiley   +1 more source

The Curious Case of Confounding Headaches. [PDF]

Case Rep Rheumatol
Chhetri RCK, Paudel H, Kaja V, Saeed J, Nwaonu J, Bankole A.   +5 more
europepmc   +1 more source

Epifagus virginiana: A review of its homoeopathic potential in stress-induced headache and migraine [PDF]

P.K. Sudhir, Anandalayam Babu Ram Jyothis   +1 more
openalex   +1 more source

Recombinant Human Neuregulin1‐β1 Significantly Reduces Schwannoma Growth in Mice

Annals of Neurology, EarlyView.
rhNRGβ1‐Replacement‐Therapy: Under physiological conditions, NRGβ1 is expressed on axons (in orange), where it activates ERBB2 receptors, facilitating successful nerve regeneration following injury. However, loss of NF2 leads to a reduction in NRGβ1‐expression and increased ErbB2 levels on Schwann cells (in green), which contributes to schwannoma ...
Julia P. Bischoff, Alexander Schulz, Christian Hagel, Robert Büttner, Michael Reuter, Waylan K. Bessler, D. Wade Clapp, Helen Morrison   +7 more
wiley   +1 more source

Impact of headache on physical activity levels and dynamic balance among university students. [PDF]

AIMS Neurosci
Selvakumar K, Fei LW, Vasu DT, Sabapathy NPV.   +3 more
europepmc   +1 more source

BOTULINUM TOXIN FOR THE TREATMENT OF CHRONIC HEADACHE

, 2016
L. B. Zavaliy, S. S. Petrikov, Г. Р. Рамазанов   +2 more
openalex   +1 more source

Combination of Serum Neurofilament Light Chain and Serum Cardiac Troponin T as Biomarkers Improves Diagnostic Accuracy in Amyotrophic Lateral Sclerosis

Annals of Neurology, EarlyView.
Objective We aimed to evaluate the clinical utility of serum neurofilament light chain (sNfL) and cardiac troponin T (cTnT) in amyotrophic lateral sclerosis (ALS) and assess whether their combination improves diagnostic accuracy. Methods We retrospectively analyzed 293 ALS patients, 85 neurodegenerative disease controls, and 29 healthy controls.
Paula Lindenborn, Rachel Fabian, Torsten Grehl, Huelya Nazlican, Thomas Meyer, Sarah Bernsen, Patrick Weydt   +6 more
wiley   +1 more source

Compare the Effect of Aromatherapy with Lavender and Valerian Essential Oil on Headache Caused by Nitroglycerin Infusion, Vital Signs, and Narcotic Use in Patients with Coronary Artery Disease: A Three-Blind, Randomized Controlled Trial. [PDF]

Iran J Nurs Midwifery Res
Yekefallah L, Mohammadi S, Ebrahimi K, Ghavanvari F, Noorian S, Moradi M.   +5 more
europepmc   +1 more source

HEADACHES IN CHILDREN AND ADOLESCENTS: CLINICAL PECULIARITIES AND PROPHYLAXIS

, 2011
Н. Н. Заваденко, Yu. E. Nesterovskiy   +1 more
openalex   +1 more source

Disruption of the Blood–Brain Barrier Predicts Progression of Cerebral Small Vessel Disease White Matter Hyperintensities

Annals of Neurology, EarlyView.
Objective The objective of this study was to test if blood–brain barrier (BBB) disruption, detected using dynamic susceptibility contrast (DSC) imaging, would predict progression of white matter hyperintensities (WMHs) over the subsequent year in patients with chronic cerebrovascular disease. Methods The study included patients with a history of stroke
Richard Leigh, Kyle C. Kern, Nae‐Yuh Wang, Rebecca F. Gottesman, Clinton B. Wright   +4 more
wiley   +1 more source